Ascendis Pharma AS annual earnings per share (EPS) for fiscal TTM was €11.20, compared with €-3.61 in fiscal 2025. All figures are reported results from public filings — no estimates or projections.
| EPS (annual) | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (EPS) | €11.20 | €-3.61 | €-6.53 | €-8.55 | €-10.40 | €-7.00 | €-8.28 | €-4.69 | €-3.17 | €-3.68 | €-2.58 | €-1.39 | €-0.57 | €0.38 | €0.12 |
EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| EPS (quarterly) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (EPS) | €2.83 | €9.91 | €-0.54 | €-1.00 | €-0.61 | €-1.58 | €-0.64 | €-1.69 | €-1.91 |
EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
More ASND metrics: Revenue · Gross Profit · Operating Income · Net Income · EBITDA · Free Cash Flow · Shares Outstanding
All ASND financial statements → Interactive ASND charts →
About TickerBase · Data methodology & sources · Privacy · Terms